John F. Greden, MD, Executive Director is Rachel Upjohn Professor of Psychiatry and Clinical Neurosciences, Chair of the Department of Psychiatry, and Director of The University of Michigan Depression Center. He also is a Senior Research Scientist in Michigan's Molecular and Behavioral Neuroscience Institute (MBNI). Dr. Greden received his Medical Degree from the University of Minnesota Medical School, completed an internship at UCLA Harbor General Medical Center in Washington, D.C. and was a resident in psychiatry at the University of Minnesota Hospitals and the Walter Reed Army Medical Center. Prior to joining the Michigan faculty, he served as a Major in the U.S. Army Medical Corps and as Director of Psychiatric Research at the Walter Reed. For the past two decades, Dr. Greden has focused upon the longitudinal course of depression, initially emphasizing serial stress-neuroendocrine measures and later the development of clinical strategies for maintaining wellness. He has published more than 260 scientific papers and edited a number of scientific books including "Treatment of Recurrent Depression."

Huda Akil, PhD is Co-Director and Senior Research Scientist Molecular and Behavioral Neuroscience Institute (MBNI), Gardner C. Quarton Distinguished Professor of Neurosciences in Psychiatry, and Professor Department of Psychiatry. She completed her masters in psychology and psycholinguistics at American University in Beirut, Lebanon, and her Ph.D. in neurosciences at University of California. Her research interests include molecular and integrative studies of emotional brain circuits. This research studies the biology of emotional circuits in the brain, and focuses on the molecular biology and integrative organization of two brain/endocrine systems: a) the brain circuits of relevance to substance abuse; and b) the mammalian stress system.

James Abelson, MD, PhD is Director, Anxiety Disorders Program and Associate Professor in the Psychiatry Department. He completed his Ph.D. in clinical psychology at Michigan State University and his M.D. at University of Michigan. His research interests focus on the psychobiology of stress and anxiety. Clinical interests include treatment of anxiety disorders (panic, obsessive-compulsive, social and specific phobias), and the value of psychological and pharmacological treatments and the most effective ways to combine these approaches to help people suffering from anxiety.

Roseanne Armitage, Ph.D joined the University of Michigan in March, 2003. She is Director of the Sleep and Chronophysiology Laboratory, Professor, Department of Psychiatry and Adjunct Professor Department of Psychology. She completed her undergraduate training in Experimental Psychology at Dalhousie University, Halifax, N.S., her Master’s and Ph.D. in Sleep Electrophysiology at Carleton University, Ottawa, Ont. and her post-doctoral fellowship at the University of Ottawa, Canada. She is the former Director of the Sleep Study Unit at the University of Texas Southwestern Medical Center at Dallas and of Director of the Sleep Study Core of the UTSW Mental Health Clinical Research Center. Dr. Armitage’s research interests include sleep and biological rhythm regulation from childhood through adulthood in healthy individuals and in those with major depressive disorders. Gender differences in brain regulation and risk factors for depression are a key focus of her research. Her research team is developing an early detection and intervention program to strengthen biological rhythm regulation and reduce the risk for development of depression.

Oliver Cameron, M.D., PhD is Professor of Psychiatry. He completed his Ph.D. in biopsychology and M.D. at University of Chicago. Visceral sensory processes, adrenergic psychobiology, psychoendocrinology, and functional brain imaging are among his research interests. His clinical interests include affective and anxiety disorders, and consultation-liaison psychiatry and psychosomatic medicine.

Duane DiFranco, MD is Medical Director, the Michigan Center for Diagnosis and Referral. He completed his M.D. at University of Michigan. Dr. DiFranco's research interests focus on behavioral health services. Clinical interests include general adult psychiatry and brief dynamic psychotherapy.

Neera Ghaziuddin, MD is an Associate Professor of Psychiatry in the Department of Psychiatry at the University of Michigan. She completed her medical degree at Delhi University in India, her residency in London, England, and her fellowship in Child Psychiatry at the University of Michigan Medical School. Her research interests include the biology of adolescent depression, treatment strategies for refractory depression, and electroconvulsive therapy. Dr. Ghaziuddin's clinical interests include depression and psychosis, and psychopharmacological treatments for these illnesses.

Stanislaw Golec, MD, PhD is Clinical Assistant Professor II in the Department of Psychiatry. He completed his M.D. at Medical Academy in Lublin, Poland and his M.P.H. at University of Michigan. Mental health economics and transcultural psychiatry are areas of research interest. Clinical interests include emergency psychiatry, stress and trauma, crisis intervention, chronic and persistent mental illness, and dual diagnosis.

Gregory Hanna, MD is former Division Director of the Child and Adolescent Division of the Department of Psychiatry, and an Associate Professor in the Department of Psychiatry. He completed his medical degree at the University of Oklahoma School of Medicine and his internship and residency at the University of Michigan Medical School. He completed his clinical and research fellowship in Child and Adolescent Psychiatry at the UCLA School of Medicine. Dr. Hanna's research interests include the genetics of obsessive-compulsive disorder and depression. His clinical interests include anxiety and mood disorders.

Helen C. Kales, MD is an Assistant Professor in the Division of Geriatric Psychiatry, Director of the Veterans Affairs Ann Arbor Healthcare System Geriatric Psychiatry Clinic, and affiliated investigator in the Geriatric Research Education and Clinical Center. Dr. Kales completed her MD at the University of Rochester School of Medicine, and psychiatry residency and geriatric psychiatry fellowship at the University of Michigan. Dr. Kales' primary research and clinical interest is in improving detection, treatment and outcomes of late-life depression.

Kevin Kerber, MD is a Clinical Assistant Professor in the Department of Psychiatry. He completed both his undergraduate and medical school training at the University of Michigan. He served as chief resident during his residency training and joined the faculty in 1984. He served as Medical Director of the Managed Care Program prior to his work in the Ambulatory Division and Depression Center. He was honored with the title of Teacher of the Year in 2000 for his outstanding teaching of residents in Psychiatry. His principle interest within psychiatry is in the area of men's psychology and depression outreach and collaborative care.

Ziad Kronfol, MD is an Associate Professor in the Department of Psychiatry. He earned his MD from the American University of Beirut. He then completed his residency training in psychiatry at the faculty at the University of Michigan in 1986 and has since been active in teaching, research and clinical care. His clinical interests include the pharmacological treatment of bipolar disorders and treatment-resistant depression. His research interests include the relation between the brain and the immune system and the effects of stress and depression on the course of medical illness.

Israel Liberzon, MD is Director PTSD Program, Co-Director Center for Trauma Stress and Anxiety, and Associate Professor of Psychiatry. He completed his postdoctoral studies in physiology at Israeli Institute of Technology and residency in psychiatry at University of Michigan. His research interests are in neurobiology of trauma and stress related disorder, neuroanatomy and neuroimaging of emotions, comorbidity of depression and anxiety, and animal models of anxiety and trauma. Clinical interests include posttraumatic stress disorder and comorbidity of depression and anxiety.

Juan Lopez, MD is a graduate of the University of Puerto Rico School of Medicine. He completed his residency training and a genetics fellowship in research at the University of Michigan Molecular and Behavioral Neuroscience Institute (MBNI). Dr. Lopez is an Assistant Professor in the Department of Psychiatry as well as an Assistant Research Scientist in the Mental Health Research Institute at the University of Michigan. His research interests have focused on depression, serotonin, and the stress axis. Dr. Lopez is a frequent lecturer to medical students, residents of other medical specialties, primary care physicians, and psychiatrists.

Dan Maixner, MD is Director, Electroconvulsive Therapy Program, Director, Neuropharmacology and New Treatments in Resistant Depression Program, and Clinical Assistant Professor in the Department of Psychiatry. He completed his M.D. at University of Nebraska Medical Center and psychiatry residency at University of Michigan. Research interests include maintenance ECT, vagus nerve stimulation for depression, and ECT in geriatric patients. Electroconvulsive therapy, inpatient psychiatry, and treatment resistant depression.

Susan Maixner, MD is Director, Geropsychiatry Clinic, and Clinical Assistant Professor II in the Department of Psychiatry. She completed her M.D. at University of Nebraska and psychiatry residency at University of Michigan. Dr. Maixner's research interests include geriatric dual diagnosis and behavioral disturbances in dementia. Clinical interests include geriatric mental health issues, geriatric dual diagnosis, and dementia.

Sheila Marcus, MD, Clinical Director of the Psychiatry Division is a graduate of the University of Michigan Medical School and completed residency training in adult, child and adolescent psychiatry at the University of Michigan. She is a Clinical Assistant Professor and Director of Ambulatory Services, and Associate Clinical Director of the Depression Center. Her academic and clinical area of interest is women's mood disorders as they present through the lifespan, including during adolescence, the childbearing years, and during menopause. Other interests are innovative uses of information technology as an educational and research tool and mental health care delivery.

Melvin McInnis M.D., Section Director - Depression Center was recently appointed the Thomas B and Nancy Upjohn Woodworth Professor of Bipolar Disorder and Depression in the Department of Psychiatry at the University of Michigan Medical School. He directs the Psychiatry programs within the University of Michigan Depression Center. He came to the University of Michigan in October 2004, relocating from the Johns Hopkins University.

Dr. McInnis did his undergrad studies at the University of Manitoba. He completed his medical training at the University of Iceland in 1983. He completed his psychiatry training at the Maudsely Hospital and Institute of Psychiatry on London UK. In 1989 he began a fellowship in Medical and Psychiatric genetics at the Johns Hopkins University. In 1993 he joined the faculty of the Department of Psychiatry at Hopkins and directed genetic studies in Bipolar disorder. He is a recognized international authority in bipolar disorder. He has several national collaborations in the genetics of bipolar disorder. He and Dr. Huda Akil are leading the Prechter Bipolar Genes Project at the University of Michigan, which aims to establish a well characterized clinical cohort of Bipolar patients as well as a DNA repository that will be available to scientists world-wide.

Alan Mellow, MD, PhD is Chief, Division of Geriatric Psychiatry, Associate Professor in the Department of Psychiatry, and Director, Mental Health Service Line, Veterans Healthcare Network 11, Department of Veterans Affairs. He completed his Ph.D. in pharmacology at Northwestern University, and his M.D. at Northwestern University. Research interests focus on experimental pharmacotherapies in Alzheimer's disease and other dementias, course and outcomes of psychiatric illness in the elderly, and neurotransmitter function and pharmacotherapy in geriatric alcoholism. Clinical interests include geriatric psychiatry and psychopharmacology, education in geriatric psychiatry, and mental health administration.

Jonathan Metzl, MD, PhD is an Assistant Professor in Psychiatry, with a joint appointment in the Women's Studies Program. Dr. Metzl directs the Program in Culture, Health and Medicine. His research explores the interactions between psychiatry, gender, and culture. Dr. Metzl is a nationally known expert on gender representations in antidepressant advertisements; his current project examines the impact of these advertisements on doctor-patient interactions. In addition, he is completing work on a history of psychotropic medications from 1950-2001, as told through medical literature and American popular culture. Dr. Metzl also teaches courses at the undergraduate and graduate level, including the "Cultural History of Depression," and "Medicine and Literature."

Randolph Nesse, MD is Professor of Psychiatry, Research Associate, Research Center for Group Dynamics, ISR, and Director, ISR Evolution and Human Adaptation Program. He completed his M.D. at University of Michigan. Current research projects include studies of depression and anxiety (utility of depression and anxiety, subtypes), Darwinian medicine, and the evolution of subjective commitment. Clinical Interests include depression and anxiety disorders.

Paresh Patel, MD, PhD is a Research Investigator at Molecular and Behavioral Neuroscience Institute (MBNI) and an Assistant Professor in the Department of Psychiatry at the University of Michigan. Upon earning his medical and doctoral degrees at the University of Michigan Medical School, he completed his internship, residency in General Psychiatry, and fellowship in Child and Adolescent Psychiatry at Stanford University Medical School. His research interests include stress biology, genetics of psychiatric illnesses, transgenic models of behavioral illnesses, and pharmacogenetics. Dr. Patel's clinical interests include mood disorders, psychopharmacology, and attention deficit disorder.

Ken Silk, MD is Vice-Chair, Faculty Group Practice Board, University of Michigan Medical Center; Associate Chair, Clinical and Administrative Affairs and Professor, Department of Psychiatry. He completed his M.D. at Albert Einstein College of Medicine and psychiatry residency at Yale University School of Medicine. Research interests include the biology of personality disorders. Clinical interests include personality disorders, psychodynamic psychotherapy, and couples therapy.

Elizabeth Young, MD, Research Director of the Psychiatry Division is a Professor of Psychiatry at the University of Michigan and a Research Scientist at the Molecular and Behavioral Neuroscience Institute (MBNI). She completed her residency training in psychiatry at Ohio State University and a fellowship in mood disorders at the University of Michigan. Dr. Young has had a long academic career in the area of depression and hypothalamic-pituitary axis (HPA) abnormalities. She has published on a variety of topics including stress and the hypothalamic pituitary axis, and the relationship of the neuroendocrine system to post-traumatic stress disorder and rheumatic diseases. She is also an experienced researcher examining gender differences in the onset and course of major depression.

Jon-Kar Zubieta, MD, PhD, Director of the Psychiatry Division earned both his medical degree and Ph.D. in Neurosciences at the University of the Basque Country Medical School in Vizcaya, Spain. He completed a residency training program in psychiatry at the University of Michigan, followed by a fellowship in nuclear medicine at Johns Hopkins in Baltimore, where he served as chief resident. Dr. Zubieta joined the Department of Psychiatry and Molecular and Behavioral Neuroscience Institute (MBNI)in 1995. Active in both research and teaching, he is studying the neurochemical, brain and functional changes associated with depression, stress responses, and their relationship with substance abuse. These measures are obtained primarily with functional brain imaging techniques.